Although there is evidence that some bacteria, such as S. aureus, can inhibit IL-8 production, thereby increasing susceptibility to infection (36), activating innate immunity without increasing neutrophil influx by these immunomodulators would indeed be a benefit worth further investigation. This evidence concerns the gene CXCL8 and infection.